INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Agios Pharmaceuticals, Inc. - AGIO
1. Pomerantz LLP is investigating Agios for potential securities fraud. 2. Agios's FDA application review for PYRUKYND extended by three months. 3. Stock price fell 11.03% after the delay announcement. 4. Investors encouraged to contact attorneys for participation in the investigation.